Related Experiment Videos

Do TNF-alpha-insensitive cancer cells escape alpha-tubulin nitrotyrosination?

H T Idriss1

  • 1School of Biomedical Sciences, University of St. Andrews, North Haugh, Fife, KY16 9ST, Scotland. hi@st-and.ac.uk

Insights

Tumor necrosis factor-alpha (TNF-alpha) may kill cancer cells via nitric oxide-mediated alpha-tubulin nitrotyrosination. Resistance to TNF-alpha might stem from reduced tubulin tyrosine ligase levels, impacting alpha-tubulin tyrosination.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Tumor necrosis factor-alpha (TNF-alpha) exhibits anti-cancer properties, but tumor resistance limits its efficacy.
  • Understanding mechanisms of TNF-alpha-induced cytotoxicity and resistance is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To hypothesize that nitric oxide-mediated alpha-tubulin posttranslational nitrotyrosination is a key mechanism for TNF-alpha's cytotoxic effects.
  • To propose that suppressed tubulin tyrosine ligase levels contribute to TNF-alpha resistance in tumors.

Main Methods:

  • Hypothetical review and synthesis of existing literature on TNF-alpha, nitric oxide, and tubulin modifications.
  • Analysis of the proposed molecular pathways involving alpha-tubulin nitrotyrosination and tyrosination.

Main Results:

  • Nitric oxide-mediated alpha-tubulin nitrotyrosination is proposed as a significant cytotoxic pathway for TNF-alpha.
  • Suppressed tubulin tyrosine ligase activity is hypothesized to underlie resistance to TNF-alpha by preventing alpha-tubulin tyrosination.

Conclusions:

  • The proposed mechanism highlights a novel pathway for TNF-alpha-induced cancer cell death.
  • Targeting tubulin tyrosine ligase or related pathways may overcome TNF-alpha resistance in certain cancers.

Related Concept Videos